product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-AP2M1 (Thr156) Antibody
catalog :
3843
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot
more info or order :
product information
SKU :
3843S
Product-Name :
Phospho-AP2M1 (Thr156) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, (M, R, Mk)
Applications :
Western blot
Product-Category :
Apoptosis
Shipping-Temp :
COLD
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
50
Host :
Rabbit
Target :
AP-2 mu2 (Thr156) phosphate
Primary-Protein :
AP2M1
Alt-Names :
AP-2 complex subunit mu,AP-2 mu 2 chain,AP-2 mu chain,AP-2 mu2,AP2M1,AP50,Adapter-related protein complex 2 mu subunit,Adaptin-mu2,Adaptor protein complex AP-2 subunit mu,CLAPM1,Clathrin assembly protein complex 2 medium chain,Clathrin coat assembly protein AP50,Clathrin coat-associated protein AP50,HA2 50 kDa subunit,KIAA0109,Plasma membrane adaptor AP-2 50 kDa protein,adaptor-related protein complex 2, mu 1 subunit,clathrin adaptor complex AP2, mu subunit,clathrin coat adaptor protein AP50,clathrin-associated/assembly/adaptor protein, medium 1,mu2,plasma membrane adaptor AP-2 50kDA protein
more info or order :
company information
Cell Signaling Technology
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.
review
product type
related products
browse more products
questions and comments